Global Push for Collaborative Safe AI in Healthcare

Building on the progress made at the AI Regulatory and International Symposium (AIRIS) in Seoul in 2024, the World Health Organization (WHO) and the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea successfully co-hosted AIRIS 2025 in Incheon, South Korea. The meeting convened regulators, academia, industry representatives, and WHO experts to guide the responsible use of artificial intelligence (AI) in the healthcare sector.

"As AI becomes more sophisticated and its health applications expand, so must our efforts to make them safe, effective, ethical, and equitable," said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

Held under the theme "Regulation for AI, Together for Tomorrow," AIRIS 2025 served as a global platform to discuss the safe, ethical, and effective use of AI in health. The symposium showcased leading regulatory frameworks and best practices for the use of AI across the medical product lifecycle. Participants underscored the importance of ensuring that AI systems are developed and deployed in ways that are safe, ethical, inclusive, and accountable.

The Outcome Statement from AIRIS Incheon 2025 calls for:

By promoting transparency, equity, and accessibility in AI governance, AIRIS 2025 has strengthened its position as a key global platform for advancing the safe and responsible use of AI in healthcare. The WHO and MFDS have reaffirmed their commitment to continue co-hosting AIRIS in the coming years, enhancing its reach and impact.